$MODV
ModivCare Inc Stock $modv

$modv Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000143774917008508 Filed on May 10, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$324.0M	$382.0M
YoY Change	-15.18%	5.42%
Cost Of Revenue	$369.4M	$348.7M
YoY Change	5.95%	-4.87%
Gross Profit	-$45.38M	$33.36M
YoY Change	-236.02%	-905.99%
Gross Profit Margin	-14.0%	8.73%
Selling, General & Admin	$16.90M	$18.50M
YoY Change	-8.65%	-5.13%
% of Gross Profit		55.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.306M	$5.521M
YoY Change	-22.01%	8.49%
% of Gross Profit		16.55%
Operating Expenses	$392.7M	$373.7M
YoY Change	5.08%	-6.35%
Operating Profit	$4.707M	$8.304M
YoY Change	-43.32%	-41.76%
Interest Expense	-$2.400M	-$3.100M
YoY Change	-22.58%	-61.25%
% of Operating Profit	-50.99%	-37.33%
Other Income/Expense, Net
YoY Change
Pretax Income	$4.438M	$5.168M
YoY Change	-14.13%	-59.55%
Income Tax	$2.523M	$3.792M
% Of Pretax Income	56.85%	73.37%
Net Earnings	-$4.325M	$2.235M
YoY Change	-293.51%	-64.16%
Net Earnings / Revenue	-1.33%	0.59%
Basic Earnings Per Share	-$0.40	$0.07
Diluted Earnings Per Share	-$0.40	$0.07
COMMON SHARES
Basic Shares Outstanding	13.70M shares	15.06M
Diluted Shares Outstanding	13.77M shares	15.19M

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.90M	$95.20M
YoY Change	-12.92%	-44.03%
Cash & Equivalents	$82.88M	$95.22M
Short-Term Investments
Other Short-Term Assets	$16.46M	$18.19M
YoY Change	-9.47%	-59.31%
Inventory
Prepaid Expenses
Receivables	$161.3M	$153.9M
Other Receivables	$14.90M	$14.80M
Total Short-Term Assets	$299.9M	$305.5M
YoY Change	-1.84%	-27.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.11M	$61.42M
YoY Change	-23.29%	4.63%
Goodwill	$119.9M	$339.2M
YoY Change	-64.66%
Intangibles	$47.53M	$275.7M
YoY Change	-82.76%
Long-Term Investments	$159.4M
YoY Change
Other Assets	$9.460M	$28.52M
YoY Change	-66.83%	-23.74%
Total Long-Term Assets	$397.9M	$720.4M
YoY Change	-44.77%	-7.46%
TOTAL ASSETS
Total Short-Term Assets	$299.9M	$305.5M
Total Long-Term Assets	$397.9M	$720.4M
Total Assets	$697.8M	$1.026B
YoY Change	-31.98%	-14.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.14M	$28.48M
YoY Change	-15.23%	-17.68%
Accrued Expenses	$111.8M	$100.3M
YoY Change	11.46%	-52.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.742M	$33.31M
YoY Change	-94.77%	22.93%
Total Short-Term Liabilities	$258.5M	$283.6M
YoY Change	-8.84%	-3.64%
LONG-TERM LIABILITIES
Long-Term Debt	$1.200M	$274.5M
YoY Change	-99.56%	-42.43%
Other Long-Term Liabilities	$25.05M	$27.45M
YoY Change	-8.75%	-8.8%
Total Long-Term Liabilities	$25.05M	$302.0M
YoY Change	-91.71%	-40.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$258.5M	$283.6M
Total Long-Term Liabilities	$25.05M	$302.0M
Total Liabilities	$342.7M	$677.3M
YoY Change	-49.4%	-24.13%
SHAREHOLDERS EQUITY
Retained Earnings	$150.5M	$70.35M
YoY Change	113.88%
Common Stock	$305.5M	$293.9M
YoY Change	3.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$144.2M	$74.40M
YoY Change	93.8%
Treasury Stock Shares	$3.944M	$2.334M
Shareholders Equity	$279.6M	$271.5M
YoY Change
Total Liabilities & Shareholders Equity	$697.8M	$1.026B
YoY Change	-31.98%	-14.41%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$4.325M	$2.235M
YoY Change	-293.51%	-64.16%
Depreciation, Depletion And Amortization	$4.306M	$5.521M
YoY Change	-22.01%	8.49%
Cash From Operating Activities	$36.20M	$34.68M
YoY Change	4.39%	125.31%
INVESTING ACTIVITIES
Capital Expenditures	$5.738M	$9.814M
YoY Change	-41.53%	53.49%
Acquisitions
YoY Change
Other Investing Activities	-$600.0K	-$700.0K
YoY Change	-14.29%	-30.0%
Cash From Investing Activities	-$6.307M	-$10.53M
YoY Change	-40.13%	42.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$18.75M	$19.58M
YoY Change	-4.22%	2615.53%
Debt Paid & Issued, Net		$7.750M
YoY Change		-89.13%
Cash From Financing Activities	-$20.41M	-13.25M
YoY Change	54.04%	-379.99%
NET CHANGE
Cash From Operating Activities	$36.20M	34.68M
Cash From Investing Activities	-$6.307M	-10.53M
Cash From Financing Activities	-$20.41M	-13.25M
Net Change In Cash	$10.03M	10.89M
YoY Change	-7.93%	-14.62%
FREE CASH FLOW
Cash From Operating Activities	$36.20M	$34.68M
Capital Expenditures	$5.738M	$9.814M
Free Cash Flow	$30.46M	$24.86M
YoY Change	22.52%	176.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	8815000
CY2017Q1	prsc	Accrued Transportation Costs Current AccruedTransportationCostsCurrent	90955000
CY2017Q1	prsc	Convertible Preferred Stock Dividends Amounts ConvertiblePreferredStockDividendsAmounts	1090000
CY2015Q1	prsc	Convertible Preferred Stock Pro Rata Share ConvertiblePreferredStockProRataShare	65500000
CY2016Q4	prsc	Accrued Transportation Costs Current AccruedTransportationCostsCurrent	72356000
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33449000
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	305521000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	302010000
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1493000
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1493000
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	612000
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5431000
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5901000
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	175000
CY2017Q1	prsc	Increase Decrease In Income Taxes Payable On Gain On Sale Of Business IncreaseDecreaseInIncomeTaxesPayableOnGainOnSaleOfBusiness
CY2017Q1	prsc	Increase Decrease Accrued Transportation Costs IncreaseDecreaseAccruedTransportationCosts	18599000
CY2016Q1	prsc	Increase Decrease Accrued Transportation Costs IncreaseDecreaseAccruedTransportationCosts	19930000
CY2016Q1	prsc	Increase Decrease In Income Taxes Payable On Gain On Sale Of Business IncreaseDecreaseInIncomeTaxesPayableOnGainOnSaleOfBusiness	-28337000
CY2017Q1	prsc	Loan To Joint Venture LoanToJointVenture	566000
CY2016Q1	prsc	Loan To Joint Venture LoanToJointVenture
CY2017Q1	prsc	Net Services Contracts Current Liability NETServicesContractsCurrentLiability	38039000
CY2016Q4	prsc	Net Services Contracts Current Liability NETServicesContractsCurrentLiability	32836000
CY2017Q1	prsc	Prepaid Taxes And Licenses PrepaidTaxesAndLicenses	2760000
CY2016Q4	prsc	Prepaid Taxes And Licenses PrepaidTaxesAndLicenses	3570000
CY2017Q1	prsc	Proceeds From Repayments Of Long Term Capita Llease Obligations And Other ProceedsFromRepaymentsOfLongTermCapitaLleaseObligationsAndOther	-670000
CY2016Q1	prsc	Proceeds From Repayments Of Long Term Capita Llease Obligations And Other ProceedsFromRepaymentsOfLongTermCapitaLleaseObligationsAndOther
CY2015Q1	prsc	Rights Offering Right To Purchase Preferred Stock Price Per Share RightsOfferingRightToPurchasePreferredStockPricePerShare	100
CY2017Q1	prsc	Stock Equivalent Units Outstanding StockEquivalentUnitsOutstanding	6671
CY2017Q1	prsc	Stock Option Equivalent Units Outstanding StockOptionEquivalentUnitsOutstanding	200000
CY2017Q1	prsc	Unfunded Equity Investment Capital Contributions UnfundedEquityInvestmentCapitalContributions
CY2016Q1	prsc	Unfunded Equity Investment Capital Contributions UnfundedEquityInvestmentCapitalContributions	1531000
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	24142000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	22177000
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161342000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	162115000
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111829000
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	102381000
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32248000
CY2017Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1963000
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	532000
CY2017Q1	us-gaap	Assets Assets	697756000
CY2016Q4	us-gaap	Assets Assets	685279000
CY2017Q1	us-gaap	Assets Current AssetsCurrent	299872000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	288103000
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82882000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72262000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	72262000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	84770000
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	82882000
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	95217000
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10620000
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10447000
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17406110
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17315661
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17406110
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17315661
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	17000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	17000
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3101000
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	730000
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	351000
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-93000
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2750000
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	637000
CY2017Q1	us-gaap	Cost Of Services CostOfServices	369410000
CY2016Q1	us-gaap	Cost Of Services CostOfServices	348676000
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2795000
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3954000
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	22756000
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	20522000
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	3622000
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	1510000
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	57939000
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	57973000
CY2017Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2805000
CY2016Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2609000
CY2017Q1	us-gaap	Depreciation Depreciation	4306000
CY2016Q1	us-gaap	Depreciation Depreciation	5521000
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6269000
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6540000
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	548000
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-442000
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.568
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.734
CY2017Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17765000
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23050000
CY2017Q1	us-gaap	Equity Method Investments EquityMethodInvestments	159360000
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	161363000
CY2017Q1	us-gaap	Escrow Deposit EscrowDeposit	10000000
CY2016Q4	us-gaap	Escrow Deposit EscrowDeposit	10000000
CY2017Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	62000
CY2016Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	75000
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17027000
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18516000
CY2017Q1	us-gaap	Goodwill Goodwill	119893000
CY2016Q4	us-gaap	Goodwill Goodwill	119624000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4438000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5168000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1915000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1376000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.03
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.03
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.02
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5866000
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	753000
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.43
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.43
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2060000
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2717000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2523000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3792000
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	454000
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	28564000
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12339000
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4071000
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1063000
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22520000
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2007000
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	516000
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2139000
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2615000
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1906000
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1735000
CY2017Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	-1404000
CY2016Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	-1728000
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-595000
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2514000
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47526000
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	49124000
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-352000
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-494000
CY2017Q1	us-gaap	Interest Paid InterestPaid	254000
CY2016Q1	us-gaap	Interest Paid InterestPaid	3165000
CY2017Q1	us-gaap	Liabilities Liabilities	342709000
CY2016Q4	us-gaap	Liabilities Liabilities	310039000
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	697756000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	685279000
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	258523000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	227796000
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1199000
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1890000
CY2017Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1742000
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1721000
CY2017Q1	us-gaap	Minority Interest MinorityInterest	-2069000
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-2420000
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20414000
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13252000
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5712000
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10534000
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36198000
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34675000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-4325000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	2235000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8397000
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9460000
CY2016Q4	us-gaap	Prepaid Rent PrepaidRent	2013000
CY2017Q1	us-gaap	Prepaid Taxes PrepaidTaxes	1488000
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	374000
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-106000
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5473000
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1002000
CY2017Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3153000
CY2016Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	3130000
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	392706000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	373732000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	6788000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8304000
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	39724000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40123000
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	16464000
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	11953000
CY2017Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1201000
CY2016Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1492000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1178000
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1201000
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1492000
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25048000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22380000
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	61000
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	43000
CY2017Q1	us-gaap	Other Receivables OtherReceivables	11696000
CY2016Q4	us-gaap	Other Receivables OtherReceivables	12639000
CY2017Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	3000
CY2016Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	5000
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18753000
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19579000
CY2017Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1272000
CY2016Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1276000
CY2017Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1090000
CY2016Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1099000
CY2017Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments
CY2016Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3229000
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5738000
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9814000
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1090000
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1099000
CY2017Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	41328000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	37895000
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41328000
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37895000
CY2017Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1583000
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3153000
CY2017Q1	us-gaap	Prepaid Rent PrepaidRent	3075000
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1467000
CY2017Q1	us-gaap	Reinsurance Payable ReinsurancePayable	7099000
CY2016Q4	us-gaap	Reinsurance Payable ReinsurancePayable	8639000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.78
CY2017Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications </div></div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have reclassified certain amounts relating to our prior period results to conform to our current period presentation. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> affiliates of Frazier Healthcare Partners purchased a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">53.2%</div> equity interest in CCHN Group Holdings, Inc. and its subsidiaries (“Matrix”) with Providence retaining a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46.8%</div> equity interest (the “Matrix Transaction”). Prior to the closing of the Matrix Transaction, the financial results of Matrix were included in the Company’s Health Assessment Services (“HA Services”) segment.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> Operating results for this segment are reported as discontinued operations, net of tax in the condensed consolidated statements of income for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> <div style="display: inline; font-style: italic;">Discontinued Operations</div><div style="display: inline; font-style: italic;">,</div><div style="display: inline; font-style: italic;"> </div>for further information<div style="display: inline; font-style: italic;">.</div> See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,</div> <div style="display: inline; font-style: italic;">Significant Accounting Policies and Recent Accounting Pronouncements</div>, for additional information on other reclassifications.</div></div></div></div></div></div></div></div>
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2016Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15000000
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	99000
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	176000
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-3951000
CY2016Q1	us-gaap	Profit Loss ProfitLoss	2129000
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47112000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46220000
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	198000
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	494000
CY2017Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7750000
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2624000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3192000
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	10911000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	10938000
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	3916000
CY2017Q1	us-gaap	Restructuring Reserve RestructuringReserve	3236000
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	8597000
CY2016Q1	us-gaap	Restructuring Reserve RestructuringReserve	8240000
CY2017Q1	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	39000
CY2016Q1	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	-252000
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	150453000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	156718000
CY2017Q1	us-gaap	Revenues Revenues	399494000
CY2016Q1	us-gaap	Revenues Revenues	382036000
CY2017Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	15000000
CY2016Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	6000000
CY2017Q1	us-gaap	Severance Costs1 SeveranceCosts1	553000
CY2016Q1	us-gaap	Severance Costs1 SeveranceCosts1	1171000
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1466000
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	612000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	313741
CY2017Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1107000
CY2017Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-770000
CY2017Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-199000
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	279551000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	300095000
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	277482000
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297675000
CY2017Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	22000
CY2017Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1301000
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	372000
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	3943985
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3478676
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	144192000
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	125201000
CY2017Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17983000
CY2017Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	58000
CY2016Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	134000
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13768524
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15185548
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13704272
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15057598

Files In Submission

Name	View Source	Status
0001437749-17-008508-index-headers.html	Edgar Link	pending
0001437749-17-008508-index.html	Edgar Link	pending
0001437749-17-008508.txt	Edgar Link	pending
0001437749-17-008508-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
prsc-20170331.xml	Edgar Link	completed
prsc-20170331.xsd	Edgar Link	pending
prsc-20170331_cal.xml	Edgar Link	unprocessable
prsc-20170331_def.xml	Edgar Link	unprocessable
prsc-20170331_lab.xml	Edgar Link	unprocessable
prsc-20170331_pre.xml	Edgar Link	unprocessable
prsc20170331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MODV
ModivCare Inc Stock $modv

2017 Q1 Form 10-Q Financial Statement

#000143774917008508 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MODV ModivCare Inc Stock $modv

2017 Q1 Form 10-Q Financial Statement

#000143774917008508 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MODV
ModivCare Inc Stock $modv